Table 2. Characteristics of the subjects... | American Society of Hematology

Table 2.

Characteristics of the subjects who experienced VTE during the study

Subject no.	Sex/age, y^*	Defect	Risk period	Location VTE
1	F/41	Factor V Leiden^†	Postpartum	Proximal DVT
2	M/66	Factor V Leiden^†	Trauma and surgery	Proximal DVT + PE
3	M/21	Factor V Leiden^†	Trauma	Proximal DVT
4	M/27	Factor V Leiden^†	Trauma and immobilization	Proximal DVT
5	F/69	Factor V Leiden^†	None	Proximal DVT
6	F/75	Factor V Leiden^†	None	Proximal DVT
7	F/59	Factor V Leiden^†	Trauma and immobilization	Proximal DVT
8	F/34	Factor V Leiden^†	Postpartum	Proximal DVT
9	M/55	None	Hip surgery	Proximal DVT
10	F/60	Prothrombin 20210A^†	None (metastatic breast cancer^‡)	Proximal DVT

Subject no.	Sex/age, y^*	Defect	Risk period	Location VTE
1	F/41	Factor V Leiden^†	Postpartum	Proximal DVT
2	M/66	Factor V Leiden^†	Trauma and surgery	Proximal DVT + PE
3	M/21	Factor V Leiden^†	Trauma	Proximal DVT
4	M/27	Factor V Leiden^†	Trauma and immobilization	Proximal DVT
5	F/69	Factor V Leiden^†	None	Proximal DVT
6	F/75	Factor V Leiden^†	None	Proximal DVT
7	F/59	Factor V Leiden^†	Trauma and immobilization	Proximal DVT
8	F/34	Factor V Leiden^†	Postpartum	Proximal DVT
9	M/55	None	Hip surgery	Proximal DVT
10	F/60	Prothrombin 20210A^†	None (metastatic breast cancer^‡)	Proximal DVT

Age at the time of VTE.

Heterozygous defect.

Diagnosis made 2 months after VTE event.